THE NEURONAL NITRIC-OXIDE SYNTHASE INHIBITOR 7-NITROINDAZOLE ALSO INHIBITS THE MONOAMINE OXIDASE-B-CATALYZED OXIDATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
K. Castagnoli et al., THE NEURONAL NITRIC-OXIDE SYNTHASE INHIBITOR 7-NITROINDAZOLE ALSO INHIBITS THE MONOAMINE OXIDASE-B-CATALYZED OXIDATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE, Chemical research in toxicology, 10(4), 1997, pp. 364-368
The neurodegenerative properties of the parkinsonian inducing agent 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) are thought to resul
t from inhibition of complex I of the mitochondrial respiratory chain
by the monoamine oxidase-B (MAO-B) generated 1-methyl-4-phenylpyridini
um metabolite MPP+. Treatment with 7-nitroindazole (7-NI) protects rod
ents and baboons against MPTP's neurotoxicity, presumably as a consequ
ence of its inhibition of neuronal nitric oxide synthase (nNOS). The r
esults reported in the present communication, while not in conflict wi
th the proposed role of nNOS, raise the possibility that the inhibitio
n of MAO-B by 7-NI also may contribute to the observed neuroprotection
.